Principal Investigator
Chih-Ping Chung,
Taipei Veterans General Hospital
Summary
| Country | Taiwan |
|---|---|
| Principal Investigator | Chih-Ping Chung, Taipei Veterans General Hospital |
| Key publication/reference | Lee YC, Chung CP, Chang MH, Wang SJ, Liao YC. NOTCH3 cysteine-altering variant is an important risk factor for stroke in the Taiwanese population. Neurology. 2020 Jan 7;94(1):e87-e96. doi: 10.1212/WNL.0000000000008700. |
| Years in which study conducted | 2009 – present (recruitment is completed) |
| Follow-up schedule | 1m, 3m, 6m, 1yr, 2yr |
| Sample | |
| Population | Hospital |
| Admit with previous stroke? | Yes |
| Age range | > 18 years old |
| Number of centres | 1 |
| Control group: number, population, selection | NA |
| Assessment | |
| Assessment timings | • 4-14 days: AD-8, MoCA, detailed tests • 3 months: MoCA • 6 months: MoCA • 1 year: MoCA, detailed tests • 2 years: MoCA, detailed tests |
| Functional tests | mRS |
| Neuropsychological/cognitive tests | Detailed neuropsychological test battery (CVVLT, BNT, verbal fluency test, CFT Taylor test, CDT, DB), Screening tests (eg MoCA, MMSE) |
| Dementia diagnosis | Yes |
| MRI scans (type e.g., T1- weighted; when and how many) |
T1-weighted volumetric,T2 weighted, FLAIR, DWI, SWI, MRA at time of the stroke, 1 year, and 2 years |
| PET scans | NA |
| Psychiatric exams | Yes |
| Genetics data (e.g., GWAS, APOE) | APOE genotype, GWAS |
| Blood analysis | Yes |
